Janiczek Wealth Management, LLC Bei Gene, Ltd. Transaction History

Janiczek Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$146.52 - $269.56 $439 - $808	-3 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$248.56 - $389.34 $497 - $778	-2 Reduced 40.0%	3 $1,000
Q3 2021 Oct 19, 2021	SELL	$249.6 - $403.14 $3,744 - $6,047	-15 Reduced 75.0%	5 $2,000
Q2 2021 Jul 28, 2021	SELL	$292.75 - $367.01 $7,611 - $9,542	-26 Reduced 56.52%	20 $7,000
Q1 2021 Apr 28, 2021	BUY	$260.64 - $382.12 $11,989 - $17,577	46 New	46 $16,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Janiczek Wealth Management, LLC with notifications on news.